journal article·2018-11-05Open access

Synergic highly effective photothermal-chemotherapy with platinum prodrug linked melanin-like nanoparticles

Chengwei Zhang, Xiaozhi Zhao, Hongqian Guo

Abstract

Cisplatin is widely used in cancer treatment, but the application is limited due to toxicities and its acquired resistance. In this study, we delivered cisplatin to prostate cancer cells by linking the platinum prodrug Pt(IV) to melanin-like nanoparticles (MeNPs), a promising photothermal therapeutic agent with excellent biocompatibility. As expected, the Pt(IV)-MeNPs exhibited brilliant synergic photothermal-chemotherapy upon near-infrared reflection exposure. Compared with free cisplatin, Pt(IV)-MeNPs displayed highly effective antitumour activity both in vitro and in vivo.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University

Funding

National Natural Science Foundation of China · Project of Invigorating Health Care through Science, Technology and Education Jiangsu Provincial Key Medical Discipline, the Social Development Project of Nanjing

References (32)

Show source-provided references
1. 10.1038/nrc216710.1038/nrc2167 ↗
2. 10.2174/092986705463762610.2174/0929867054637626 ↗
3. 10.3109/21691401.2015.100851010.3109/21691401.2015.1008510 ↗
4. 10.1038/nrd169110.1038/nrd1691 ↗
5. 10.1021/cr980421n10.1021/cr980421n ↗
6. 10.1002/chem.20120315910.1002/chem.201203159 ↗
7. 10.1021/jm300580y10.1021/jm300580y ↗
8. 10.1021/nn500152u10.1021/nn500152u ↗
9. 10.1021/nn301148e10.1021/nn301148e ↗
10. 10.1016/j.biomaterials.2011.06.07210.1016/j.biomaterials.2011.06.072 ↗
11. 10.1158/0008-5472.CAN-12-456110.1158/0008-5472.CAN-12-4561 ↗
12. 10.1021/nn305011p10.1021/nn305011p ↗
13. 10.1016/j.biomaterials.2013.01.01010.1016/j.biomaterials.2013.01.010 ↗
14. 10.1016/j.biomaterials.2013.12.01810.1016/j.biomaterials.2013.12.018 ↗
15. 10.1080/21691401.2018.150803010.1080/21691401.2018.1508030 ↗
16. 10.1016/j.biomaterials.2011.07.07110.1016/j.biomaterials.2011.07.071 ↗
17. 10.1080/21691401.2017.142007210.1080/21691401.2017.1420072 ↗
18. 10.1080/21691401.2018.145026510.1080/21691401.2018.1450265 ↗
19. 10.1002/adma.20130189010.1002/adma.201301890 ↗
20. 10.1016/j.biomaterials.2015.01.07410.1016/j.biomaterials.2015.01.074 ↗
21. 10.1002/adma.20120468310.1002/adma.201204683 ↗
22. 10.1080/21691401.2017.138438410.1080/21691401.2017.1384384 ↗
23. 10.1021/cr400407a10.1021/cr400407a ↗
24. 10.1002/adma.20070197410.1002/adma.200701974 ↗
25. 10.1021/nn500722y10.1021/nn500722y ↗
26. 10.1021/am503583s10.1021/am503583s ↗
27. 10.1021/jp064341w10.1021/jp064341w ↗
28. 10.1021/bm100396s10.1021/bm100396s ↗
29. 10.1113/jphysiol.1973.sp01008610.1113/jphysiol.1973.sp010086 ↗
30. 10.1002/adma.20080122210.1002/adma.200801222 ↗
31. 10.1021/nn404117j10.1021/nn404117j ↗
32. 10.1016/j.jinorgbio.2004.05.01710.1016/j.jinorgbio.2004.05.017 ↗